Role of EKG in Adult Patients with Suspected Pneumonia
An electrocardiogram should be obtained in all hospitalized pneumonia patients with cardiovascular risk factors or signs of cardiac complications, as pneumonia causes cardiac arrhythmias in 9.5-12% of cases and can precipitate myocardial infarction, heart failure, and other life-threatening cardiac events. 1
Primary Indications for EKG in Pneumonia
High-Risk Patients Requiring Cardiac Monitoring
Obtain a baseline EKG immediately in pneumonia patients with at least 6 of these risk factors: 1
- Age >65 years
- Chronic heart disease
- Chronic kidney disease
- Tachycardia on presentation
- Septic shock
- Multilobar pneumonia
- Hypoalbuminemia
- Pneumococcal pneumonia
Patients meeting 6 or more criteria have a 21.2% risk of acute cardiac complications and warrant continuous electrocardiographic monitoring, typically in an ICU setting. 1
Cardiovascular Complications Detected by EKG
Pneumonia triggers a spectrum of cardiac events that manifest on EKG: 1
- Arrhythmias (9.5-12% incidence): atrial fibrillation, ventricular tachycardia/fibrillation, symptomatic bradycardia, and cardiac arrest 1
- Myocardial infarction (1.5% incidence) 1
- Heart failure exacerbation (10.2% incidence) 1
- Pericarditis and myocarditis 1
These complications occur primarily during hospitalization but can develop up to 90 days after admission, with older age, heart failure history, and need for mechanical ventilation or vasopressors increasing risk. 1
Specific EKG Abnormalities in Pneumonia
Common Findings
EKG abnormalities occur in 31-39% of pneumonia patients without underlying cardiopulmonary disease: 2, 3
QRS Complex Changes (39% of patients): 2
- Right axis deviation (9.7%)
- S₁S₂S₃ pattern (9.7%)
- Complete right bundle branch block (4.8%)
- S₁Q₃T₃ pattern (4.8%)
- Clockwise rotation (16%)
ST-Segment and T-Wave Abnormalities (21-30%): 2, 4
- Minor nonspecific ST-segment or T-wave changes are the most prevalent abnormality beyond sinus tachycardia 2
- ST-segment depression correlates with increased mortality risk 5
- Right atrial enlargement (6.5-9.8%)
- P pulmonale pattern
Reversibility and Clinical Significance
These EKG changes are typically acute and reversible, resolving within 2 days to 1 month after recovery. 2, 3 However, certain patterns carry prognostic significance:
- S₁Q₃T₃ pattern correlates with cardiac enzyme elevation (CK-MB), hypoxia, and illness severity 3
- P pulmonale, right axis deviation, and clockwise rotation correlate with hypoxia and high severity scores 3
- QTc prolongation increases mortality risk (OR 3.17) 5
- Atrial fibrillation dramatically increases mortality (OR 12.74) 5
Monitoring Strategy and Timing
Initial Assessment
Obtain a baseline 12-lead EKG on all pneumonia patients with: 1
- Known cardiovascular disease
- Suspected cardiac dysfunction
- High-risk features (≥6 risk factors)
- Signs of hemodynamic instability
The baseline EKG provides instantaneous information about arrhythmias, conduction defects, chamber enlargement, myocardial ischemia, and electrolyte disturbances that may not be available through other tests. 1
Serial Monitoring
Repeat EKGs are indicated when: 1
- Clinical status changes (new symptoms, hemodynamic deterioration)
- Inadequate response to therapy after 72 hours 1
- Administering antibiotics with proarrhythmic effects (QTc monitoring for fluoroquinolones, macrolides) 1
- Electrolyte abnormalities develop, particularly hypokalemia 1
Continuous Telemetry
Continuous electrocardiographic monitoring is standard in ICU settings for pneumonia patients. 1 For patients on general telemetry units, continuous monitoring is reasonable for those with ≥6 high-risk factors, though prospective studies validating this approach in non-ICU settings are lacking. 1
Differential Diagnosis Considerations
EKG Cannot Distinguish Pneumonia from Pulmonary Embolism
A critical pitfall: EKG findings in pneumonia are similar to those in pulmonary embolism, and electrocardiography cannot assist in differential diagnosis. 2 Both conditions produce:
- Right axis deviation
- S₁Q₃T₃ pattern
- Right bundle branch block
- ST-segment and T-wave abnormalities
When PE is suspected clinically, definitive imaging (CT pulmonary angiography) is required regardless of EKG findings. 1
Distinguishing Cardiac vs. Pulmonary Pathology
When EKG shows abnormalities in pneumonia patients not improving with therapy, consider: 1
- Cardiac complications: myocardial infarction, heart failure, pericarditis, endocarditis
- Pulmonary complications: empyema, lung abscess, ARDS
- Thromboembolic disease: pulmonary embolism with infarction
Echocardiography, cardiac biomarkers (troponin, BNP), and repeat chest imaging help differentiate these entities. 1
Antibiotic-Related EKG Monitoring
QTc Interval Surveillance
Monitor QTc interval when using antibiotics with proarrhythmic effects: 1
- Fluoroquinolones (levofloxacin, moxifloxacin)
- Macrolides (azithromycin, clarithromycin)
- Combination therapy increases risk
Hypokalemia potentiates antibiotic-induced QT prolongation and arrhythmias. 1 Maintain potassium ≥4.0 mEq/L in patients with heart failure receiving these agents. 1
Late-Onset Cardiac Complications
EKG abnormalities in pneumonia may exhibit delayed onset, appearing an average of 30 days after symptom onset (range 12-51 days). 4 These late complications:
- Do not progress in parallel with pulmonary abnormalities 4
- May occur after negative nasopharyngeal swabs 4
- Include new-onset atrial fibrillation, ST-T changes, tachy-brady syndrome, and pericarditis 4
This delayed presentation underscores the need for vigilance beyond the acute hospitalization period, particularly in patients with cardiovascular risk factors. 1
Prognostic Value
Specific EKG findings predict outcomes: 5
- Sinus rhythm at admission is protective (HR 2.7 for survival) 5
- Atrial fibrillation increases mortality 12-fold 5
- ST-segment depression increases mortality 5-fold 5
However, the presence of EKG abnormalities alone does not predict mortality when controlling for other clinical factors—the underlying severity of illness and associated complications drive outcomes. 3